Gyrodyne (GYRO) Stock Price, News & Analysis

Company Overview

Gyrodyne Company of America, Inc. is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.

The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island. This portfolio features a diversified mix of multi-tenant buildings that house outpatient services, rehabilitation centers and specialty laboratories. Gyrodyne’s strategic approach involves acquiring under-utilized or newly developed properties, investing in targeted capital improvements, and securing long-term leases with creditworthy tenants. Through hands-on property management and an emphasis on tenant retention, the firm aims to enhance asset value and maintain a resilient revenue base.

Originally founded in 1959 and initially engaged in rotorcraft design and manufacturing, Gyrodyne transitioned to a real estate-focused business in the late 1980s. Over the decades, the company has built deep ties to the greater Long Island region, leveraging local market knowledge and zoning expertise to support its development initiatives. Led by an experienced management team and overseen by a board of directors with backgrounds in real estate and healthcare industries, Gyrodyne continues to pursue opportunities that align with its mission of delivering high-quality, medically oriented real estate solutions to its tenant community.

Key Stats

• Today's Range: $9.84 to $10.21
• 50-Day Range: $8.50 to $10.70
• 52-Week Range: $6.80 to $12.00
• Volume: 4,062 shs
• Average Volume: 5,582 shs
• Market Capitalization: $22.39 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Gyrodyne Stock Analysis - MarketRank™

Gyrodyne scored higher than 38% of companies evaluated by MarketBeat, and ranked 783rd out of 946 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Gyrodyne .

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Gyrodyne has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of Gyrodyne has been sold short.

Short Interest Ratio / Days to Cover

Gyrodyne has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Gyrodyne has recently decreased by 90.91%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Gyrodyne does not currently pay a dividend.

Dividend Growth

Gyrodyne does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.01% of the float of Gyrodyne has been sold short.

Short Interest Ratio / Days to Cover

Gyrodyne has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Gyrodyne has recently decreased by 90.91%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.21

News Sentiment

Gyrodyne has a news sentiment score of 1.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.06 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Gyrodyne this week, compared to 0 articles on an average week.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Gyrodyne insiders have not sold or bought any company stock.

Percentage Held by Insiders

12.10% of the stock of Gyrodyne is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

71.36% of the stock of Gyrodyne is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

GYRO Stock Analysis - Frequently Asked Questions

How have GYRO shares performed this year?

Gyrodyne 's stock was trading at $9.02 on January 1st, 2025. Since then, GYRO shares have increased by 13.8% and is now trading at $10.2650.

How do I buy shares of Gyrodyne ?

Shares of GYRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Gyrodyne own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Gyrodyne investors own include Meta Platforms (META), Acasti Pharma (ACST), Amyris (AMRS), Ariad Pharmaceuticals (ARIA), Astrotech (ASTC), Athersys (ATHX) and (AVNR) (AVNR).

Company Calendar

• Today: 9/12/2025
• Next Earnings (Estimated): 11/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: REAL ESTATE OPS
• Sub-Industry: Diversified REITs
• Current Symbol: NASDAQ:GYRO
• CIK: 1589061
• Web: www.gyrodyne.com
• Phone: (631) 584-5400
• Fax: 631-584-7075
• Employees: 6
• Year Founded: 1946

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $19.51 per share
• Price / Book: 0.51

Miscellaneous

• Outstanding Shares: 2,200,000
• Free Float: 1,933,000
• Market Cap: $21.91 million
• Optionable: Not Optionable
• Beta: 0.38